Showing results (11-20 of 28) with videos related to
Sort By:
Pageof 3
Transplantation|November 15, 2001
Inhibition of angiogenesis-related endothelial activity by the experimental immunosuppressive agent leflunomideW J Waldman, A Bickerstaff, G Gordillo, et al.Transplantation|December 1, 1993
In vitro induction of endothelial HLA class II antigen expression by cytomegalovirus-activated CD4+ T cellsW J Waldman, D A Knight, P W Adams, et al.Transplantation|August 27, 1994
Alloantigenicity of human endothelial cells. III. Quantitated indirect presentation of endothelial alloantigens to human helper T lymphocytesP W Adams, H S Lee, W J Waldman, et al.Human Immunology|August 10, 1999
Trans vivo analysis of human delayed-type hypersensitivity reactivityL Carrodeguas, C G Orosz, W J Waldman, et al.Transplantation|March 8, 2000
Attenuation of cytomegalovirus-induced endothelial intercellular adhesion molecule-1 mRNA/protein expression and T lymphocyte adhesion by a 2'-O-methoxyethyl antisense oligonucleotideD A Knight, B R Briggs, C F Bennett, et al.Clinical Chemistry|August 1, 1997
Increased alkaline phosphatase isoforms in autoimmune diseasesA N Hanna, W J Waldman, J A Lott, et al.Archives of Virology|January 1, 1991
Preservation of natural endothelial cytopathogenicity of cytomegalovirus by propagation in endothelial cellsW J Waldman, W H Roberts, D H Davis, et al.Transplantation|February 24, 2001
Inhibition of herpes simplex virus type 1 by the experimental immunosuppressive agent leflunomideD A Knight, A Q Hejmanowski, J E Dierksheide, et al.The American Journal of Pathology|April 1, 1994
Cytomegalovirus inhibits major histocompatibility class II expression on infected endothelial cellsD D Sedmak, A M Guglielmo, D A Knight, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 26, 2006
Concurrent antiviral and immunosuppressive activities of leflunomide in vivoA S Chong, H Zeng, D A Knight, et al.Pageof 3